´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼ : À¯Çüº°, ¾à¹°º°, ¹é½Åº°, Åõ¿© °æ·Îº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032
»óǰÄÚµå
:
1424031
¸®¼Ä¡»ç
:
Polaris Market Research
¹ßÇàÀÏ
:
2024³â 01¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 115 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 46¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
¹ÙÀÌ·¯½ºÀÇ Àü¿°¼ºÀÌ ³ô±â ¶§¹®¿¡ Á¤ºÎ ±â°ü°ú »ç¶÷µéÀº °¡´ÉÇÑ ÇÑ »¡¸® Ä¡·á¸¦ ¹Þ¾Æ¾ß ÇÕ´Ï´Ù. ´Ü¼øÆ÷ÁøÀº ÀÎü °¨¿°·ü¿¡ µû¶ó µÎ °¡Áö À¯ÇüÀ¸·Î ³ª´µ´Âµ¥, HSV-1Àº º¸Åë °¨¿°ÀÚÀÇ ÇǺΠÁ¢ÃËÀ» ÅëÇØ °¨¿°µË´Ï´Ù. ¹Ý¸é, HSV-2´Â ÀÔ¼ú Ç츣Æä½ºÀ̸ç, ÁÖ·Î ¼Ò¾Æ±â¿¡ °¨¿°µÈ »ç¶÷ÀÇ Å¸¾×°ú ¼ºÇàÀ§ ÀÌ¿ÜÀÇ Á¢ÃËÀ» ÅëÇØ °¨¿°µË´Ï´Ù. ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½ºÀÇ È¿À²ÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÑ Å« ÀÌÀ¯ Áß Çϳª´Â ÇÑ ¹ø °¨¿°µÇ¸é Æò»ý Áö¼ÓµÉ ¼ö ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù.
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º´Â ÀÎü¿¡ µé¾î°¡¸é Àẹ ³×Æ®¿öÅ©¸¦ Çü¼ºÇϰí, 1ÁÖÀÏ¿¡¼ 10ÀÏ Á¤µµ¸é »ç¶óÁöÁö¸¸ ÄÚ¿Í ÀÔ ÁÖº¯ ÇǺο¡ ÅëÁõÀ» µ¿¹ÝÇÑ ¹°ÁýÀÌ »ý±æ ¼ö ÀÖ½À´Ï´Ù. °æ¿ì¿¡ µû¶ó ´Ü¼øÆ÷ÁøÀº À¯ÇØÇÑ ³ú¿°À̳ª ¾È±¸ °¨¿°À» À¯¹ßÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º´Â Àü ¼¼°è Àα¸ÀÇ ¾à 2/3°¡ ¾Î°í ÀÖÀ» Á¤µµ·Î »çȸÀûÀ¸·Î ÈçÇÑ Áúº´ÀÔ´Ï´Ù. ÀÌ´Â ¼¼°è ½ÃÀå¿¡¼ ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·áÀÇ º»ÁúÀ» °Á¶Çϰí ÀÖ½À´Ï´Ù.
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á¸¦ À§ÇÑ »õ·Î¿î Ä¡·á¹ýÀ» Çõ½ÅÇϱâ À§ÇÑ ¿¬±¸ °³¹ß Ȱµ¿ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ°¡ ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, Nature Communications¿¡ °ÔÀçµÈ 2023³â ¿¬±¸´Â ¼¼Æ÷ ȯ°æ°ú ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º À¯Çü 1ÀÇ °ü°è¸¦ ޱ¸ÇÏ¿© µÎ °¡Áö°¡ ¼·Î ¿¬°üµÇ¾î ÀÖÀ½À» ¹àÇû½À´Ï´Ù. ÀÌ·¯ÇÑ ¿¬±¸´Â ¿¹Ãø ±â°£ µ¿¾È ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·áÀÇ ¹ßÀüÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ, ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á¸¦ À§ÇÑ Çõ½ÅÀûÀÎ ¹é½Å¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÏ¸é¼ ½ÃÀå ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Shenzhen Mellow Hope Pharm Industrial°ú Rational Vaccines´Â Áß±¹¿¡¼ Ç츣Æä½º ¹é½ÅÀ» °³¹ßÇϱâ À§ÇØ Àü·«Àû Á¦ÈÞ¸¦ ¸Î¾ú½À´Ï´Ù.
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º-1(HSV-1) ºÎ¹®Àº ³ôÀº °¨¿°·ü·Î ÀÎÇØ ÇâÈÄ ¸î ³â µ¿¾È °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¹ß¶ó½ÃŬ·Î¹ö ºÎ¹®Àº Ä¡·áÁ¦ÀÇ ³ôÀº Èí¼öÀ²·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº °¨¿°ÀÚ¿ÍÀÇ Á¢ÃË À§ÇèÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸ñÂ÷
¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå ÀλçÀÌÆ®
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á - ¾÷°è ÇöȲ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀΰú ±âȸ
¼¼°èÀÇ °¨¿°·ü »ó½Â
¼¼Æ÷ Ä¡·á ¹× À¯ÀüÀÚ Ä¡·á¸¦ ޱ¸ÇÏ´Â ¿¬±¸ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÃßÁø
¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
±ÔÁ¦»ó ÇãµéÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °¡´É¼ºÀÌ ÀÖ´Ù
PESTLE ºÐ¼®
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ¾÷°è µ¿Çâ
COVID-19 °¨¿°ÁõÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, À¯Çüº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º-1(HSV-1)
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º-2(HSV-2)
Á¦6Àå ¼¼°èÀÇ ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¾àÁ¦º°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
¾Æ½ÃŬ·Î¹ö
¹ß¶ó½ÃŬ·Î¹ö
ÆÊ½ÃŬ·Î¹ö
±âŸ ¾à¹°
Á¦7Àå ¼¼°èÀÇ ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¹é½Åº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
½ÉÇø®¸¯½º
±âŸ
Á¦8Àå ¼¼°èÀÇ ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, Åõ¿© °æ·Îº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
°æ±¸
ÁÖ»ç
±¹¼Ò
Á¦9Àå ¼¼°èÀÇ ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ÃÖÁ¾ ¿ëµµº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
º´¿ø ¾à±¹
¼Ò¸Å ¾à±¹
¿Â¶óÀÎ ¾à±¹
Á¦10Àå ¼¼°èÀÇ ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, Áö¿ªº°
ÁÖ¿ä Á¶»ç °á°ú
¼·Ð
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ºÏ¹Ì
ºÏ¹Ì : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
ºÏ¹Ì : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
ºÏ¹Ì : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¾àÁ¦º°, 2019-2032³â
ºÏ¹Ì : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¹é½Åº°, 2019-2032³â
ºÏ¹Ì : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ¹Ì±¹
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ij³ª´Ù
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - À¯·´
À¯·´ : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
À¯·´ : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
À¯·´ : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¾àÁ¦º°, 2019-2032³â
À¯·´ : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¹é½Åº°, 2019-2032³â
À¯·´ : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ¿µ±¹
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ÇÁ¶û½º
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - µ¶ÀÏ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ÀÌÅ»¸®¾Æ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ½ºÆäÀÎ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ³×´ú¶õµå
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ·¯½Ã¾Æ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
¾Æ½Ã¾ÆÅÂÆò¾ç : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¾àÁ¦º°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¹é½Åº°, 2019-2032³â
¾Æ½Ã¾ÆÅÂÆò¾ç : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - Áß±¹
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - Àεµ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ÀϺ»
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ¸»·¹À̽þÆ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - Àεµ³×½Ã¾Æ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - Çѱ¹
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¾àÁ¦º°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¹é½Åº°, 2019-2032³â
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - À̽º¶ó¿¤
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ³²¾ÆÇÁ¸®Ä«°øÈ±¹
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
¶óƾ¾Æ¸Þ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, À¯Çüº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, Åõ¿© °æ·Îº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¾àÁ¦º°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ¹é½Åº°, 2019-2032³â
¶óƾ¾Æ¸Þ¸®Ä« : ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ¸ß½ÃÄÚ
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ºê¶óÁú
´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º Ä¡·á ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª
Á¦11Àå °æÀï »óȲ
È®Àå°ú Àμö ºÐ¼®
Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³
Á¦12Àå ±â¾÷ °³¿ä
Apotex Inc.
Carlsbad Tech
Emcure Pharmaceuticals Ltd.
Fresenius Kabi AG
GSK plc
Glenmark Pharmaceuticals Inc.
Novartis AG
Sanofi
Teva Pharmaceuticals Industries Ltd.
Viatris, Inc.
ksm
¿µ¹® ¸ñÂ÷
The global herpes simplex virus treatment market size is expected to reach USD 4.66 billion by 2032, according to a new study by Polaris Market Research. The report "Herpes Simplex Virus Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Herpes Simplex Virus-1, Herpes simplex virus-2); By Drug; By Vaccine; By Route of Administration; By End-use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The higher transmission potential of viruses is forcing government agencies and people to get treatment as quickly as possible. Herpes simplex is a virus that is divided into two types based on the infection rate among humans. HSV-1 is usually transmitted through skin-to-skin contact from the infected person. At the same time, HSV-2 is an oral herpes that mostly infects children during childhood due to non-sexual contact with the saliva of infected people. One of the major factors driving the need for efficient treatment of the herpes simplex virus is that if a person gets infected once, then it can last forever.
The herpes simplex virus builds a latent network once it gets inside the human body. While it is likely to vanish after a week to ten days, it can cause painful blisters on the skin around the nose and mouth. In some cases, herpes simplex may lead to harmful brain inflammation and eye infections. According to the World Health Organization, the herpes simplex virus is a more common disease in society, affecting about two-thirds of the world population. This is emphasizing the essence of herpes simplex virus treatment in the global market.
The growing research and development activities to innovate new therapies with the potential to cure herpes simplex virus treatment are expected to showcase significant growth opportunities in the market. For instance, a 2023 study published in Nature Communications explored the relationship between the cellular landscape and herpes simplex virus type 1 and revealed that both are connected. These research studies are expected to drive advancements in herpes simplex virus treatment during the forecast period.
Moreover, rising investments in innovative vaccines for the treatment of the herpes simplex virus are significantly driving market growth. For instance, Shenzhen Mellow Hope Pharm Industrial. & Rational Vaccines entered into a strategic collaboration to develop herpes vaccines in China.
Herpes Simplex Virus Treatment Market Report Highlights
The Herpes Simplex Virus-1 (HSV-1) segment is anticipated to witness the highest growth in the coming years due to the higher rate of transmission.
Valacyclovir segment accounted for the largest market share owing to the potential for a higher absorption rate of treatment.
Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the risk of contact with infected persons.
The global players include Apotex Inc., Carlsbad Tech, Emcure Pharmaceuticals Ltd., Fresenius Kabi AG, GSK plc, Glenmark Pharmaceuticals Inc., & Novartis AG.
Polaris Market Research has segmented the herpes simplex virus treatment market report based on type, drug, vaccine, route of administration, end-use, and region:
Herpes Simplex Virus Treatment, Type Outlook (Revenue - USD Billion, 2019 - 2032)
Herpes Simplex Virus-1 (HSV-1)
Herpes simplex virus-2 (HSV-2)
Herpes Simplex Virus Treatment, Drug Outlook (Revenue - USD Billion, 2019 - 2032)
Acyclovir
Valacyclovir
Famciclovir
Other Drugs
Herpes Simplex Virus Treatment, Vaccine Outlook (Revenue - USD Billion, 2019 - 2032)
Herpes Simplex Virus Treatment, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)
Herpes Simplex Virus Treatment, End-use Outlook (Revenue - USD Billion, 2019 - 2032)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Herpes Simplex Virus Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
3. Research Methodology
3.1. Overview
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Herpes Simplex Virus Treatment Market Insights
4.1. Herpes Simplex Virus Treatment - Industry Snapshot
4.2. Herpes Simplex Virus Treatment Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. The rising infection rate in the world
4.2.1.2. The rising studies exploring cell and gene therapies are driving the market growth
4.2.2. Restraints and Challenges
4.2.2.1. Regulatory hurdles are likely to impede market growth
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Herpes Simplex Virus Treatment Industry Trends
4.6. COVID-19 Impact Analysis
5. Global Herpes Simplex Virus Treatment Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
5.3. Herpes Simplex Virus-1 (HSV-1)
5.3.1. Global Herpes Simplex Virus Treatment Market, by Herpes Simplex Virus-1 (HSV-1), by Region, 2019-2032 (USD Billion)
5.4. Herpes simplex virus-2 (HSV-2)
5.4.1. Global Herpes Simplex Virus Treatment Market, by Herpes simplex virus-2 (HSV-2), by Region, 2019-2032 (USD Billion)
6. Global Herpes Simplex Virus Treatment Market, by Drug
6.1. Key Findings
6.2. Introduction
6.2.1. Global Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
6.3. Acyclovir
6.3.1. Global Herpes Simplex Virus Treatment Market, by Acyclovir, by Region, 2019-2032 (USD Billion)
6.4. Valacyclovir
6.4.1. Global Herpes Simplex Virus Treatment Market, by Valacyclovir, by Region, 2019-2032 (USD Billion)
6.5. Famciclovir
6.5.1. Global Herpes Simplex Virus Treatment Market, by Famciclovir, by Region, 2019-2032 (USD Billion)
6.6. Other Drugs
6.6.1. Global Herpes Simplex Virus Treatment Market, by Other Drugs, by Region, 2019-2032 (USD Billion)
7. Global Herpes Simplex Virus Treatment Market, by Vaccine
7.1. Key Findings
7.2. Introduction
7.2.1. Global Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
7.3. Simplirix
7.3.1. Global Herpes Simplex Virus Treatment Market, by Simplirix, by Region, 2019-2032 (USD Billion)
7.4. Others
7.4.1. Global Herpes Simplex Virus Treatment Market, by Others, by Region, 2019-2032 (USD Billion)
8. Global Herpes Simplex Virus Treatment Market, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.2.1. Global Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
8.3. Oral
8.3.1. Global Herpes Simplex Virus Treatment Market, by Oral, by Region, 2019-2032 (USD Billion)
8.4. Injectable
8.4.1. Global Herpes Simplex Virus Treatment Market, by Injectable, by Region, 2019-2032 (USD Billion)
8.5. Topical
8.5.1. Global Herpes Simplex Virus Treatment Market, by Topical, by Region, 2019-2032 (USD Billion)
9. Global Herpes Simplex Virus Treatment Market, by End Use
9.1. Key Findings
9.2. Introduction
9.2.1. Global Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
9.3. Hospital Pharmacy
9.3.1. Global Herpes Simplex Virus Treatment Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
9.4. Retail Pharmacy
9.4.1. Global Herpes Simplex Virus Treatment Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
9.5. Online Pharmacy
9.5.1. Global Herpes Simplex Virus Treatment Market, by Online Pharmacy, by Region, 2019-2032 (USD Billion)
10. Global Herpes Simplex Virus Treatment Market, by Geography
10.1. Key findings
10.2. Introduction
10.2.1. Herpes Simplex Virus Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
10.3. Herpes Simplex Virus Treatment Market - North America
10.3.1. North America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.3.2. North America: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.3.3. North America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.3.4. North America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.3.5. North America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.3.6. Herpes Simplex Virus Treatment Market - U.S.
10.3.6.1. U.S.: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.3.6.2. U.S.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.3.6.3. U.S.: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.3.6.4. U.S.: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.3.6.5. U.S.: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.3.7. Herpes Simplex Virus Treatment Market - Canada
10.3.7.1. Canada: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.3.7.2. Canada.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.3.7.3. Canada: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.3.7.4. Canada: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.3.7.5. Canada: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.4. Herpes Simplex Virus Treatment Market - Europe
10.4.1. Europe: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.4.2. Europe.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.3. Europe: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.4.4. Europe: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.4.5. Europe: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.4.6. Herpes Simplex Virus Treatment Market - UK
10.4.6.1. UK: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.4.6.2. UK.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.6.3. UK: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.4.6.4. UK: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.4.6.5. UK: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.4.7. Herpes Simplex Virus Treatment Market - France
10.4.7.1. France: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.4.7.2. France.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.7.3. France: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.4.7.4. France: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.4.7.5. France: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.4.8. Herpes Simplex Virus Treatment Market - Germany
10.4.8.1. Germany: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.4.8.2. Germany.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.8.3. Germany: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.4.8.4. Germany: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.4.8.5. Germany: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.4.9. Herpes Simplex Virus Treatment Market - Italy
10.4.9.1. Italy: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.4.9.2. Italy.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.9.3. Italy: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.4.9.4. Italy: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.4.9.5. Italy: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.4.10. Herpes Simplex Virus Treatment Market - Spain
10.4.10.1. Spain: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.4.10.2. Spain.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.10.3. Spain: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.4.10.4. Spain: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.4.10.5. Spain: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.4.11. Herpes Simplex Virus Treatment Market - Netherlands
10.4.11.1. Netherlands: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.4.11.2. Netherlands.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.11.3. Netherlands: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.4.11.4. Netherlands: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.4.11.5. Netherlands: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.4.12. Herpes Simplex Virus Treatment Market - Russia
10.4.12.1. Russia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.4.12.2. Russia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.4.12.3. Russia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.4.12.4. Russia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.4.12.5. Russia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.5. Herpes Simplex Virus Treatment Market - Asia Pacific
10.5.1. Asia Pacific: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.5.2. Asia Pacific.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.3. Asia Pacific: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.5.4. Asia Pacific: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.5.5. Asia Pacific: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.5.6. Herpes Simplex Virus Treatment Market - China
10.5.6.1. China: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.5.6.2. China.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.6.3. China: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.5.6.4. China: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.5.6.5. China: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.5.7. Herpes Simplex Virus Treatment Market - India
10.5.7.1. India: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.5.7.2. India.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.7.3. India: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.5.7.4. India: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.5.7.5. India: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.5.8. Herpes Simplex Virus Treatment Market - Japan
10.5.8.1. Japan: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.5.8.2. Japan.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.8.3. Japan: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.5.8.4. Japan: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.5.8.5. Japan: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.5.9. Herpes Simplex Virus Treatment Market - Malaysia
10.5.9.1. Malaysia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.5.9.2. Malaysia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.9.3. Malaysia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.5.9.4. Malaysia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.5.9.5. Malaysia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.5.10. Herpes Simplex Virus Treatment Market - Indonesia
10.5.10.1. Indonesia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.5.10.2. Indonesia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.10.3. Indonesia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.5.10.4. Indonesia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.5.10.5. Indonesia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.5.11. Herpes Simplex Virus Treatment Market - South Korea
10.5.11.1. South Korea: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.5.11.2. South Korea.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.5.11.3. South Korea: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.5.11.4. South Korea: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.5.11.5. South Korea: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.6. Herpes Simplex Virus Treatment Market - Middle East & Africa
10.6.1. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.6.2. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.3. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.6.4. Middle East & Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.6.5. Middle East & Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.6.6. Herpes Simplex Virus Treatment Market - Saudi Arabia
10.6.6.1. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.6.6.2. Saudi Arabia.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.6.3. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.6.6.4. Saudi Arabia: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.6.6.5. Saudi Arabia: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.6.7. Herpes Simplex Virus Treatment Market - UAE
10.6.7.1. UAE: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.6.7.2. UAE.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.7.3. UAE: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.6.7.4. UAE: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.6.7.5. UAE: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.6.8. Herpes Simplex Virus Treatment Market - Israel
10.6.8.1. Israel: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.6.8.2. Israel.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.8.3. Israel: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.6.8.4. Israel: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.6.8.5. Israel: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.6.9. Herpes Simplex Virus Treatment Market - South Africa
10.6.9.1. South Africa: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.6.9.2. South Africa.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.6.9.3. South Africa: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.6.9.4. South Africa: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.6.9.5. South Africa: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.7. Herpes Simplex Virus Treatment Market - Latin America
10.7.1. Latin America: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.7.2. Latin America.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.7.3. Latin America: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.7.4. Latin America: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.7.5. Latin America: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.7.6. Herpes Simplex Virus Treatment Market - Mexico
10.7.6.1. Mexico: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.7.6.2. Mexico.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.7.6.3. Mexico: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.7.6.4. Mexico: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.7.6.5. Mexico: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.7.7. Herpes Simplex Virus Treatment Market - Brazil
10.7.7.1. Brazil: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.7.7.2. Brazil.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.7.7.3. Brazil: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.7.7.4. Brazil: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.7.7.5. Brazil: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
10.7.8. Herpes Simplex Virus Treatment Market - Argentina
10.7.8.1. Argentina: Herpes Simplex Virus Treatment Market, by Type, 2019-2032 (USD Billion)
10.7.8.2. Argentina.: Herpes Simplex Virus Treatment Market, by Route of Administration, 2019-2032 (USD Billion)
10.7.8.3. Argentina: Herpes Simplex Virus Treatment Market, by Drug, 2019-2032 (USD Billion)
10.7.8.4. Argentina: Herpes Simplex Virus Treatment Market, by Vaccine, 2019-2032 (USD Billion)
10.7.8.5. Argentina: Herpes Simplex Virus Treatment Market, by End Use, 2019-2032 (USD Billion)
11. Competitive Landscape
11.1. Expansion and Acquisition Analysis
11.1.1. Expansion
11.1.2. Acquisitions
11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
12.1. Apotex Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Benchmarking
12.1.4. Recent Development
12.2. Carlsbad Tech
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Benchmarking
12.2.4. Recent Development
12.3. Emcure Pharmaceuticals Ltd.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Benchmarking
12.3.4. Recent Development
12.4. Fresenius Kabi AG
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Benchmarking
12.4.4. Recent Development
12.5. GSK plc
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Benchmarking
12.5.4. Recent Development
12.6. Glenmark Pharmaceuticals Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Benchmarking
12.6.4. Recent Development
12.7. Novartis AG
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Benchmarking
12.7.4. Recent Development
12.8. Sanofi
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Benchmarking
12.8.4. Recent Development
12.9. Teva Pharmaceuticals Industries Ltd.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Benchmarking
12.9.4. Recent Development
12.10. Viatris, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Benchmarking
12.10.4. Recent Development
°ü·ÃÀÚ·á